Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Exchange Rate Effect (2023 - 2025)

Historic Exchange Rate Effect for Rhythm Pharmaceuticals (RYTM) over the last 3 years, with Q3 2025 value amounting to $304000.0.

  • Rhythm Pharmaceuticals' Exchange Rate Effect rose 15041.46% to $304000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 18568.98%. This contributed to the annual value of $2000.0 for FY2024, which is 10140.85% up from last year.
  • As of Q3 2025, Rhythm Pharmaceuticals' Exchange Rate Effect stood at $304000.0, which was up 15041.46% from -$279000.0 recorded in Q2 2025.
  • Rhythm Pharmaceuticals' 5-year Exchange Rate Effect high stood at $977000.0 for Q4 2024, and its period low was -$603000.0 during Q3 2024.
  • Moreover, its 3-year median value for Exchange Rate Effect was -$71000.0 (2024), whereas its average is -$10636.4.
  • The largest annual percentage gain for Rhythm Pharmaceuticals' Exchange Rate Effect in the last 5 years was 60885.42% (2024), contrasted with its biggest fall of 88311.69% (2024).
  • Rhythm Pharmaceuticals' Exchange Rate Effect (Quarter) stood at -$192000.0 in 2023, then soared by 608.85% to $977000.0 in 2024, then plummeted by 68.88% to $304000.0 in 2025.
  • Its Exchange Rate Effect stands at $304000.0 for Q3 2025, versus -$279000.0 for Q2 2025 and -$2000.0 for Q1 2025.